Pourquoi Sam Altman prend-il de la Metformine ?
GeoGazet Renseignement· Mise à jour 5 octobre 2026· 1 min de lecture· 791 vues
There is no credible evidence that Sam Altman, OpenAI's CEO since 2019, takes metformin.
This claim lacks substantiation in public records, health disclosures, or verified reporting.
Altman's health information remains private.
Lire le rapport completAfficher moins
Pourquoi Sam Altman prend-il de la Metformine ?
Public Focus on AI Development
Altman's documented activities center on OpenAI's product roadmap. Recent initiatives include OpenAI Dots, his unveiled ChatGPT AI personal agent, alongside the 2026 DevDay announcements. His tracked signals show 94 connections to Artificial Intelligence developments.
Speculation Without Basis
Health rumors about prominent figures often circulate online without verification. Without direct statements from Altman or credible medical sources, claims about his medications should be treated as unsubstantiated speculation rather than fact.
Suivez Altman en direct.Chaque mise à jour est publiée sur notre Telegram.
Rejoindre sur TelegramAvis des lecteurs
Aucun avis pour le moment. Soyez le premier à partager votre point de vue.